Download full-text PDF

Source
http://dx.doi.org/10.1007/s00063-007-1049-9DOI Listing

Publication Analysis

Top Keywords

[pseudotumoral laryngeal
4
laryngeal tuberculosis]
4
[pseudotumoral
1
tuberculosis]
1

Similar Publications

Pseudoglandular hyperplasia of the conjunctiva: A rare entity.

J Fr Ophtalmol

January 2025

Department of Pathology, Habib Bourguiba University Hospital, Sfax, Tunisia. Electronic address:

Objective: Pseudoglandular hyperplasia of the conjunctiva (PHC) is a rare benign epithelial pseudotumor. We report herein a new case of this rare entity, review its histopathological features and discuss its differential diagnoses.

Methods: The morphologic findings of PHC of the right eye occurring in a 65-year-old man are reported with a review of the related literature.

View Article and Find Full Text PDF

Granulation tissue-like spindle cell (sarcomatoid) carcinoma of the head and neck: a deceptively bland-looking underdiagnosed malignancy.

Virchows Arch

May 2024

Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center (CCC) Erlangen-EMN, 91054, Erlangen, Germany.

The diagnosis of head and neck spindle cell squamous carcinoma (SC-SCC) is often challenging. Lesions with a prominent inflammatory infiltrate and reactive vessels may have a granulation tissue-like appearance, therefore being difficult to distinguish from reactive lesions, like contact ulcers, post-intubation granulomas, inflammatory pseudotumors, or benign vascular lesions. In this study, we analyzed the clinicopathological features of a series of 17 head and neck SC-SCC with granulation tissue-like appearance.

View Article and Find Full Text PDF

Laryngeal tuberculosis: about 04 cases.

Pan Afr Med J

December 2023

Department of Radiology, Avicenna, Military Hospital, Marrakech, Morocco.

The purpose of this study is to present epidemiological, clinical, radiological, histological characteristics and treatment of laryngeal tuberculosis. It is also aimed at making the point about diagnosis difficulties. This retrospective study was conducted over three years; it concerned 4 cases, 3 males and one female.

View Article and Find Full Text PDF

Pseudotumor of the Larynx: A Previously Unreported Side Effect of Apremilast.

Case Rep Dermatol

December 2020

Department of Ear Nose and Throat, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Apremilast (Otezla®) is a relatively novel orally administered non-biologic disease-modifying anti-rheumatic drug (DMARD) extensively used in the management of psoriasis and psoriasis arthritis, lately approved for treating oral ulcerations in Behçets disease. Its advantageous side effect profile together with its uncomplicated follow-up and monitoring when compared to other DMARDs facilitates even a broad off-label prescribing. Here, the first case of laryngeal pseudotumor in a patient treated with apremilast for plaque psoriasis is presented.

View Article and Find Full Text PDF

Imaging of IgG4-Related Disease in the Head and Neck: A Systematic Review, Case Series, and Pathophysiology Update.

J Neuroradiol

September 2021

Division of Neuroradiology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address:

This systematic review aims to clarify and comprehensively detail the sometimes variable published imaging features as well as the pathogenesis, clinical diagnostic criteria, and treatment options of IgG4-Related Diseases (IgG4-RD) in the head and neck to aid the radiologist in diagnosing relapse and new sites of disease. A literature search in PubMed and EMBASE for reported cases of IgG4-RD was performed in December 2019. Case reports or series of IgG4-RD in the head and neck in adults that included sufficient imaging and pathology findings were included.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!